These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20661667)

  • 1. Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer.
    Piña-Sánchez P; Hernández-Hernández DM; Taja-Chayeb L; Cerda-Flores RM; González-Herrera AL; Rodea-Avila C; Apresa-García T; Ostrosky-Wegman P; Vázquez-Ortíz G; Mendoza-Lorenzo P; Dueñas-González A; Salcedo M
    Med Oncol; 2011 Dec; 28(4):1507-13. PubMed ID: 20661667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigens I and II haplotypes associated with human papillomavirus 16-positive invasive cervical cancer in Mexican women.
    Hernández-Hernández DM; Cerda-Flores RM; Juárez-Cedillo T; Granados-Arriola J; Vargas-Alarcón G; Apresa-García T; Alvarado-Cabrero I; García-Carrancá A; Salcedo-Vargas M; Mohar-Betancourt A
    Int J Gynecol Cancer; 2009 Aug; 19(6):1099-106. PubMed ID: 19820376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
    Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
    Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women.
    Assoumou SZ; Boumba AL; Ndjoyi-Mbiguino A; Khattabi A; Ennaji MM
    Med Oncol; 2015 Jan; 32(1):281. PubMed ID: 25502079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 polymorphism, HPV infection, and risk of cervical cancer.
    Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women.
    Isakova J; Vinnikov D; Bukuev N; Talaibekova E; Aldasheva N
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1057-1062. PubMed ID: 31030474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of APOBEC3G Polymorphism with Human Papillomavirus (HPV) Persistent Infection and Progression of Cervical Lesions.
    Sui S; Chen H; Han L; Wang L; Niyazi M; Zhu K
    Med Sci Monit; 2019 Sep; 25():6990-6997. PubMed ID: 31527570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India.
    Pillai MR; Sreevidya S; Pollock BH; Jayaprakash PG; Herman B
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):627-31. PubMed ID: 12458344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53, MDM2, NQO1, and susceptibility to cervical cancer.
    Hu X; Zhang Z; Ma D; Huettner PC; Massad LS; Nguyen L; Borecki I; Rader JS
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):755-61. PubMed ID: 20200430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between p53 Arg72Pro polymorphism and cervical carcinoma in Uigur and Han women in Xinjiang].
    Zheng XZ; Yang AQ; Pan XL; Zheng LL; Zhou QY; Li XM; Wang XL; Yan LH; Li HA
    Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):511-5. PubMed ID: 17980096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia.
    Koushik A; Ghosh A; Duarte-Franco E; Forest P; Voyer H; Matlashewski G; Coutlée F; Franco EL;
    Cancer Detect Prev; 2005; 29(4):307-16. PubMed ID: 16122882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 polymorphism at exon 4 in caucasian women from eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions.
    Humbey O; Aubin F; Cairey-Remonnay S; Riethmuller D; Pretet JL; Fest T; Seilles E; Mougin C
    Eur J Obstet Gynecol Reprod Biol; 2002 Jun; 103(1):60-4. PubMed ID: 12039466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women.
    Roh JW; Kim BK; Lee CH; Kim J; Chung HH; Kim JW; Park NH; Song YS; Park SY; Kang SB
    Oncol Res; 2010; 18(9):453-9. PubMed ID: 20524403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
    Yin CM; Yao YF; Yan ZL; Yang HY
    Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
    Alsbeih GA; Al-Harbi NM; Bin Judia SS; Khoja HA; Shoukri MM; Tulbah AM
    Cancer; 2017 Jul; 123(13):2459-2466. PubMed ID: 28393355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus.
    Chagas BS; Lima RCP; Paiva Júnior SSL; Silva RCO; Cordeiro MN; Silva Neto JDC; Batista MVA; Silva AJD; Gurgel APAD; Freitas AC
    Cytokine; 2019 Jan; 113():99-104. PubMed ID: 29935877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions.
    Min-min H; Ming-rong X; Ze-yi C; Kai-xuan Y; Zhi-lin S
    Int J Gynecol Cancer; 2006; 16(6):2004-8. PubMed ID: 17177838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited.
    Koshiol J; Hildesheim A; Gonzalez P; Bratti MC; Porras C; Schiffman M; Herrero R; Rodriguez AC; Wacholder S; Yeager M; Chanock SJ; Burk RD; Wang SS
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1631-7. PubMed ID: 19423538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MTHFR/p53 polymorphisms as genetic factors for cervical intraepithelial neoplasia and cervical cancer in HPV-infected Mexican women.
    González-Herrera L; Rodríguez-Morales P; Gonza Lez-Losa Mdel R; Pérez-Mendoza G; Canul-Canché J; Rosado-López I; Cetina TC
    Int J Biol Markers; 2014 Jun; 29(2):e142-9. PubMed ID: 24474455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma.
    Singhal P; Hussain S; Thakur N; Batra S; Salhan S; Bhambani S; Bharadwaj M
    DNA Cell Biol; 2013 Jan; 32(1):19-27. PubMed ID: 23210739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.